{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:28:55Z","timestamp":1770416935898,"version":"3.49.0"},"reference-count":27,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"2","license":[{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2021,2,23]]},"DOI":"10.1167\/tvst.10.2.35","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T16:52:58Z","timestamp":1614099178000},"page":"35","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of Polypoidal Choroidal Vasculopathy Lesion Sizes Measured on Multicolor Imaging and Indocyanine Green Angiography"],"prefix":"10.1167","volume":"10","author":[{"given":"Louis W.","family":"Lim","sequence":"first","affiliation":[{"name":"National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin S.","family":"Tan","sequence":"additional","affiliation":[{"name":"National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore"},{"name":"Fundus Image Reading Center, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore"},{"name":"Duke-NUS Medical School, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic S.","family":"Ting","sequence":"additional","affiliation":[{"name":"National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27","reference":[{"issue":"8","key":"bib1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00417-003-0667-z","article-title":"Polypoidal choroidal vasculopathy in elderly Chinese patients","volume":"242","author":"Wen","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"bib2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","article-title":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients","volume":"144","author":"Maruko","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"bib3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/eye.2009.323","article-title":"Polypoidal choroidal vasculopathy: an angiographic discussion","volume":"24","author":"Lim","year":"2010","journal-title":"Eye (Lond)"},{"issue":"1","key":"bib4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ophtha.2007.02.031","article-title":"One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients","volume":"115","author":"Gomi","year":"2008","journal-title":"Ophthalmology"},{"issue":"10","key":"bib5","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/archopht.121.10.1392","article-title":"Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics","volume":"121","author":"Sho","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"bib6","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy","volume":"32","author":"Koh","year":"2012","journal-title":"Retina"},{"issue":"7","key":"bib7","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study a randomized clinical trial","volume":"136","author":"Lee","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"bib8","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial","volume":"135","author":"Koh","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"bib9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3928\/23258160-20171215-01","article-title":"New paradigms in polypoidal choroidal vasculopathy management: the impact of recent multicenter, randomized clinical trials","volume":"49","author":"Tan","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"8","key":"bib10","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3928\/23258160-20150909-02","article-title":"Current management of polypoidal choroidal vasculopathy","volume":"46","author":"Tan","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"9","key":"bib11","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","article-title":"Comparison of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: the EVEREST II randomized clinical trial","volume":"138","author":"Lim","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"bib12","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1136\/bjophthalmol-2014-305059","article-title":"A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes","volume":"98","author":"Tan","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"bib13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bjophthalmol-2014-305674","article-title":"EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy","volume":"99","author":"Tan","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"bib14","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1167\/iovs.17-22683","article-title":"EVEREST report 5: clinical outcomes and treatment response of polypoidal choroidal vasculopathy subtypes in a multicenter, randomized controlled trial","volume":"59","author":"Tan","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"bib15","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.ajo.2014.08.025","article-title":"Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy","volume":"158","author":"De Salvo","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"bib16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jamaophthalmol.2019.0565","article-title":"Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy","volume":"137","author":"Chaikitmongkol","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"bib17","doi-asserted-by":"publisher","first-page":"OCT324","DOI":"10.1167\/iovs.15-18898","article-title":"Characteristics of polypoidal choroidal vasculopathy evaluated by optical coherence tomography angiography","volume":"57","author":"Tomiyasu","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"bib18","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1097\/IAE.0000000000002139","article-title":"Sensitivity and specificity of detecting polypoidal choroidal vasculopathy with en face optical coherence tomography and optical coherence tomography angiography","volume":"39","author":"De Carlo","year":"2019","journal-title":"Retina"},{"issue":"5","key":"bib19","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/ceo.2019.47.issue-5","article-title":"EVEREST study report 4: fluorescein angiography features predictive of polypoidal choroidal vasculopathy","volume":"47","author":"Tan","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"bib20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/01.iae.0000249386.63482.05","article-title":"Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy","volume":"27","author":"Sato","year":"2007","journal-title":"Retina"},{"issue":"11","key":"bib21","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1136\/bjophthalmol-2015-307892","article-title":"Optical coherence tomography angiography characteristics of polypoidal choroidal vasculopathy","volume":"100","author":"Srour","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"bib22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.oret.2019.01.009","article-title":"Multicolor fundus imaging of polypoidal choroidal vasculopathy","volume":"3","author":"Tan","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"bib23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/ceo.2019.47.issue-5","article-title":"Multicolour imaging for the detection of polypoidal choroidal vasculopathy and age-related macular degeneration","volume":"47","author":"Tan","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"issue":"9","key":"bib24","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1097\/IAE.0000000000001777","article-title":"Identifying features of early and late age-related macular degeneration: a comparison of multicolor versus traditional color fundus photography","volume":"38","author":"Graham","year":"2018","journal-title":"Retina"},{"issue":"10","key":"bib25","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00417-016-3333-y","article-title":"EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study","volume":"254","author":"Tan","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"bib26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/eye.2016.232","article-title":"Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy","volume":"31","author":"Takayama","year":"2017","journal-title":"Eye (Lond)"},{"issue":"6","key":"bib27","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1097\/IAE.0000000000001702","article-title":"Polypoidal choroidal vasculopathy upon optical coherence tomographic angiography","volume":"38","author":"Chan","year":"2018","journal-title":"Retina"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2772317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T16:53:01Z","timestamp":1614099181000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2772317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,5]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.10.2.35","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,23]]}}}